CK2/PIM1-IN-1

• UNSPSC Description:

  CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1, with IC50s of 3.787 μM and 4.327 μM for CK2 and PIM1, respectively. CK2/PIM1-IN-1 is developed for the research of proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, vascular disorders, pathogenic infections and certain immunological disorders[1].

• Target Antigen:

  Casein Kinase; Pim

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage;JAK/STAT Signaling;Stem Cell/Wnt

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Cancer; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/ck2-pim1-in-1.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(O)C1=CC=CC=C1C2=CC=C(/C=C(SC(N3)=S)\C3=O)O2

• Molecular Weight:

  331.37

• References & Citations:

  [1]Mustapha Haddach, et al. Rhodanines and related heterocycles as kinase inhibitors. WO2010148351A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  292640-28-9